Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 6473 | 38.5 |
09:33 ET | 934 | 38.67 |
09:35 ET | 700 | 38.58 |
09:37 ET | 2105 | 38.7 |
09:39 ET | 2422 | 38.91 |
09:42 ET | 500 | 38.91 |
09:44 ET | 2987 | 38.84 |
09:46 ET | 2565 | 39.14 |
09:48 ET | 300 | 39.15 |
09:50 ET | 600 | 39.22 |
09:51 ET | 5300 | 39.13 |
09:53 ET | 6107 | 39.17 |
09:55 ET | 900 | 39.21 |
09:57 ET | 9174 | 39.31 |
10:00 ET | 900 | 39.32 |
10:02 ET | 1000 | 39.25 |
10:04 ET | 1449 | 39.275 |
10:06 ET | 2858 | 39.53 |
10:08 ET | 9162 | 39.46 |
10:09 ET | 1695 | 39.43 |
10:11 ET | 300 | 39.5 |
10:13 ET | 7505 | 39.53 |
10:15 ET | 10061 | 39.36 |
10:18 ET | 400 | 39.34 |
10:20 ET | 100 | 39.26 |
10:22 ET | 1024 | 39.21 |
10:24 ET | 100 | 39.2 |
10:26 ET | 1400 | 39.18 |
10:27 ET | 3010 | 39.133 |
10:29 ET | 906 | 39.165 |
10:31 ET | 2818 | 39.19 |
10:33 ET | 2934 | 39.185 |
10:36 ET | 2400 | 39.19 |
10:38 ET | 1736 | 39.18 |
10:40 ET | 4406 | 39.08 |
10:42 ET | 1300 | 39.085 |
10:44 ET | 300 | 39.18 |
10:45 ET | 1627 | 39.12 |
10:47 ET | 200 | 39.115 |
10:49 ET | 700 | 39.165 |
10:51 ET | 830 | 39.145 |
10:54 ET | 3600 | 39.105 |
10:56 ET | 8677 | 39.095 |
10:58 ET | 1309 | 38.98 |
11:00 ET | 600 | 38.955 |
11:02 ET | 4105 | 39.0536 |
11:03 ET | 529 | 39.05 |
11:05 ET | 400 | 39.08 |
11:07 ET | 1600 | 39.02 |
11:09 ET | 599 | 38.98 |
11:12 ET | 100 | 38.98 |
11:14 ET | 3300 | 38.975 |
11:16 ET | 1396 | 38.98 |
11:18 ET | 200 | 39.04 |
11:20 ET | 800 | 39.055 |
11:21 ET | 925 | 39.07 |
11:23 ET | 309 | 39.08 |
11:25 ET | 1100 | 39.06 |
11:27 ET | 900 | 39.1 |
11:30 ET | 1630 | 39.085 |
11:32 ET | 6980 | 38.995 |
11:34 ET | 300 | 38.99 |
11:36 ET | 1529 | 39.005 |
11:38 ET | 300 | 39.02 |
11:39 ET | 1898 | 39.02 |
11:41 ET | 570 | 39.035 |
11:43 ET | 1806 | 38.995 |
11:45 ET | 800 | 39.045 |
11:50 ET | 430 | 39.05 |
11:52 ET | 2000 | 39.035 |
11:54 ET | 2326 | 39.015 |
11:56 ET | 360 | 39.01 |
11:57 ET | 1066 | 38.96 |
11:59 ET | 1000 | 38.91 |
12:01 ET | 1800 | 38.9 |
12:03 ET | 6955 | 38.88 |
12:06 ET | 3570 | 38.93 |
12:08 ET | 700 | 38.98 |
12:10 ET | 1700 | 39.02 |
12:12 ET | 380 | 39.02 |
12:14 ET | 1400 | 38.9736 |
12:15 ET | 1113 | 38.94 |
12:17 ET | 1370 | 38.965 |
12:19 ET | 4430 | 39.0057 |
12:21 ET | 400 | 39.06 |
12:24 ET | 692 | 39.12 |
12:26 ET | 1557 | 39.13 |
12:28 ET | 200 | 39.125 |
12:30 ET | 937 | 39.14 |
12:32 ET | 1429 | 39.11 |
12:33 ET | 400 | 39.125 |
12:35 ET | 1173 | 39.14 |
12:37 ET | 615 | 39.14 |
12:39 ET | 245 | 39.14 |
12:42 ET | 400 | 39.14 |
12:44 ET | 3668 | 39.12 |
12:46 ET | 1063 | 39.16 |
12:48 ET | 734 | 39.19 |
12:50 ET | 300 | 39.22 |
12:51 ET | 1600 | 39.17 |
12:53 ET | 1348 | 39.185 |
12:55 ET | 900 | 39.14 |
12:57 ET | 500 | 39.12 |
01:00 ET | 1824 | 39.08 |
01:02 ET | 500 | 39.055 |
01:04 ET | 1134 | 39.04 |
01:06 ET | 600 | 39.03 |
01:08 ET | 518 | 39.06 |
01:09 ET | 1160 | 39.02 |
01:11 ET | 2500 | 39.17 |
01:13 ET | 1798 | 39.18 |
01:15 ET | 1230 | 39.215 |
01:18 ET | 1596 | 39.17 |
01:20 ET | 1000 | 39.2 |
01:22 ET | 800 | 39.16 |
01:24 ET | 800 | 39.19 |
01:26 ET | 2256 | 39.124 |
01:27 ET | 1200 | 39.17 |
01:29 ET | 273 | 39.1705 |
01:31 ET | 2629 | 39.12 |
01:33 ET | 1196 | 39.125 |
01:36 ET | 941 | 39.14 |
01:38 ET | 1017 | 39.13 |
01:40 ET | 1100 | 39.15 |
01:42 ET | 617 | 39.16 |
01:44 ET | 200 | 39.15 |
01:45 ET | 1865 | 39.205 |
01:47 ET | 600 | 39.22 |
01:49 ET | 1410 | 39.22 |
01:51 ET | 1531 | 39.24 |
01:54 ET | 600 | 39.24 |
01:56 ET | 1907 | 39.23 |
01:58 ET | 1000 | 39.18 |
02:00 ET | 2172 | 39.18 |
02:02 ET | 1200 | 39.14 |
02:03 ET | 900 | 39.1 |
02:05 ET | 4627 | 39.065 |
02:07 ET | 956 | 39.09 |
02:09 ET | 1135 | 39.0542 |
02:12 ET | 3321 | 38.9999 |
02:14 ET | 4114 | 38.995 |
02:16 ET | 704 | 38.96 |
02:18 ET | 1020 | 38.95 |
02:20 ET | 1200 | 38.94 |
02:21 ET | 2602 | 38.92 |
02:23 ET | 1036 | 38.9 |
02:25 ET | 3818 | 38.98 |
02:27 ET | 600 | 39.005 |
02:30 ET | 400 | 39.035 |
02:32 ET | 762 | 39.05 |
02:34 ET | 1790 | 39.12 |
02:36 ET | 2278 | 39.085 |
02:38 ET | 2414 | 39.05 |
02:39 ET | 1913 | 39.04 |
02:41 ET | 749 | 39.045 |
02:43 ET | 1462 | 39.03 |
02:45 ET | 900 | 39.03 |
02:48 ET | 801 | 39.06 |
02:50 ET | 38909 | 39.06 |
02:52 ET | 400 | 39.06 |
02:54 ET | 5941 | 39.07 |
02:56 ET | 800 | 39.115 |
02:57 ET | 1500 | 39.105 |
02:59 ET | 60997 | 38.91 |
03:01 ET | 1706 | 38.865 |
03:03 ET | 5010 | 38.81 |
03:06 ET | 3421 | 38.81 |
03:08 ET | 7162 | 38.88 |
03:10 ET | 2748 | 38.9 |
03:12 ET | 1771 | 38.915 |
03:14 ET | 3932 | 38.85 |
03:15 ET | 3105 | 38.88 |
03:17 ET | 800 | 38.9 |
03:19 ET | 2500 | 38.925 |
03:21 ET | 1615 | 38.91 |
03:24 ET | 860 | 38.88 |
03:26 ET | 2948 | 38.865 |
03:28 ET | 5904 | 38.89 |
03:30 ET | 5182 | 38.96 |
03:32 ET | 1295 | 39.04 |
03:33 ET | 3604 | 39.07 |
03:35 ET | 2586 | 39.13 |
03:37 ET | 3988 | 39.08 |
03:39 ET | 802 | 39.07 |
03:42 ET | 5340 | 39.09 |
03:44 ET | 2915 | 39.1 |
03:46 ET | 2765 | 39.0717 |
03:48 ET | 4904 | 39.07 |
03:50 ET | 2134 | 39.15 |
03:51 ET | 5861 | 39.14 |
03:53 ET | 7709 | 39.15 |
03:55 ET | 11704 | 39.15 |
03:57 ET | 8909 | 39.11 |
04:00 ET | 203256 | 39.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 6.2B | -16.0x | --- |
Blueprint Medicines Corp | 6.4B | -47.8x | --- |
ACADIA Pharmaceuticals Inc | 2.9B | 22.8x | --- |
Ultragenyx Pharmaceutical Inc | 4.7B | -7.8x | --- |
ADMA Biologics Inc | 5.3B | 160.9x | --- |
Legend Biotech Corp | 7.4B | -25.5x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.2B |
---|---|
Revenue (TTM) | $803.1M |
Shares Outstanding | 157.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.37 |
EPS | $-2.45 |
Book Value | $2.68 |
P/E Ratio | -16.0x |
Price/Sales (TTM) | 7.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -46.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.